A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias

James W. Hawkins, Jared R. Tinkletiberg, Javaid Sheikh, Carol E. Peyser, Jerome A. Yesavage

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

In a 24-patient case series from retrospective chart review, the authors examined the use of gabapentin for the treatment of aggressive and agitated behaviors in nursing home patients with a DSM-IV diagnosis of dementia. On Clinical Global Rating Scale scores, 17 of 22 patients were much or greatly improved; 4 were minimally improved; and only 1 remained unchanged. Two of the 24 patients discontinued use of the medication because of excessive sedation. No other significant side effects were noted in treatment lasting up to 2 years.

Original languageEnglish
Pages (from-to)221-225
Number of pages5
JournalAmerican Journal of Geriatric Psychiatry
Volume8
Issue number3
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Dementia
Therapeutics
Nursing Homes
Diagnostic and Statistical Manual of Mental Disorders
gabapentin

ASJC Scopus subject areas

  • Medicine(all)
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. / Hawkins, James W.; Tinkletiberg, Jared R.; Sheikh, Javaid; Peyser, Carol E.; Yesavage, Jerome A.

In: American Journal of Geriatric Psychiatry, Vol. 8, No. 3, 2000, p. 221-225.

Research output: Contribution to journalArticle

Hawkins, James W. ; Tinkletiberg, Jared R. ; Sheikh, Javaid ; Peyser, Carol E. ; Yesavage, Jerome A. / A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. In: American Journal of Geriatric Psychiatry. 2000 ; Vol. 8, No. 3. pp. 221-225.
@article{8c6d1f84512d4d0890b73d6373745755,
title = "A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias",
abstract = "In a 24-patient case series from retrospective chart review, the authors examined the use of gabapentin for the treatment of aggressive and agitated behaviors in nursing home patients with a DSM-IV diagnosis of dementia. On Clinical Global Rating Scale scores, 17 of 22 patients were much or greatly improved; 4 were minimally improved; and only 1 remained unchanged. Two of the 24 patients discontinued use of the medication because of excessive sedation. No other significant side effects were noted in treatment lasting up to 2 years.",
author = "Hawkins, {James W.} and Tinkletiberg, {Jared R.} and Javaid Sheikh and Peyser, {Carol E.} and Yesavage, {Jerome A.}",
year = "2000",
doi = "10.1097/00019442-200008000-00007",
language = "English",
volume = "8",
pages = "221--225",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias

AU - Hawkins, James W.

AU - Tinkletiberg, Jared R.

AU - Sheikh, Javaid

AU - Peyser, Carol E.

AU - Yesavage, Jerome A.

PY - 2000

Y1 - 2000

N2 - In a 24-patient case series from retrospective chart review, the authors examined the use of gabapentin for the treatment of aggressive and agitated behaviors in nursing home patients with a DSM-IV diagnosis of dementia. On Clinical Global Rating Scale scores, 17 of 22 patients were much or greatly improved; 4 were minimally improved; and only 1 remained unchanged. Two of the 24 patients discontinued use of the medication because of excessive sedation. No other significant side effects were noted in treatment lasting up to 2 years.

AB - In a 24-patient case series from retrospective chart review, the authors examined the use of gabapentin for the treatment of aggressive and agitated behaviors in nursing home patients with a DSM-IV diagnosis of dementia. On Clinical Global Rating Scale scores, 17 of 22 patients were much or greatly improved; 4 were minimally improved; and only 1 remained unchanged. Two of the 24 patients discontinued use of the medication because of excessive sedation. No other significant side effects were noted in treatment lasting up to 2 years.

UR - http://www.scopus.com/inward/record.url?scp=0033945096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033945096&partnerID=8YFLogxK

U2 - 10.1097/00019442-200008000-00007

DO - 10.1097/00019442-200008000-00007

M3 - Article

C2 - 10910420

AN - SCOPUS:0033945096

VL - 8

SP - 221

EP - 225

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 3

ER -